Last reviewed · How we verify

NCT06770387

Telenursing and Transitional Care

Completed NA Last updated 10 September 2025
What this trial tests

NA trial testing mhealth in Lumbar Disc Surgery in 107 participants. Completed in 30 May 2025.

Timeline
24 December 2024
Primary endpoint
30 May 2025
30 May 2025

Quick facts

Lead sponsorHasan Kalyoncu University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposehealth services research
Enrollment107
Start date24 December 2024
Primary completion30 May 2025
Estimated completion30 May 2025
Sites4 locations across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Hasan Kalyoncu University

Who can join

18 and older, any sex, with Lumbar Disc Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Post-operative care for Lumbar Disc Herniation (LDH) is important to reduce postoperative complications. The transition from hospital to home after discharge is important for LDH patients, as the transition process is flawless, the necessary care is provided appropriately, and follow-up is important. The aim of the study is to determine the effects of transitional model-based telenursing and mobile application-based follow-up on fall risk, post-discharge recovery, mobility, anxiety, and complications in patients who underwent lumbar disc surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of mhealth

Trials testing the same drug.

Other Hasan Kalyoncu University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06770387.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing